What is the current valuation of the South Korea structural heart-devices market?

The market valuation was $19.25 Million in 2024. Read More

What is the projected market size for the South Korea structural heart-devices market by 2035?

The projected valuation for 2035 is $42.15 Million. Read More

What is the expected CAGR for the South Korea structural heart-devices market during the forecast period 2025 - 2035?

The expected CAGR is 7.38% during the forecast period. Read More

Which companies are the key players in the South Korea structural heart-devices market?

Key players include Edwards Lifesciences, Medtronic, Abbott Laboratories, and Boston Scientific. Read More

What are the main segments of the South Korea structural heart-devices market?

The main segments include Type, Procedure Type, Indication, and End User. Read More

What was the valuation of Transcatheter Aortic Valve Replacement in 2024?

The valuation for Transcatheter Aortic Valve Replacement was $5.0 Million in 2024. Read More

How much is the Mitral Valve Repair Devices segment projected to grow by 2035?

The Mitral Valve Repair Devices segment is projected to grow to $9.5 Million by 2035. Read More

What is the expected valuation for Left Atrial Appendage Closure Devices in 2035?

The expected valuation for Left Atrial Appendage Closure Devices is $7.0 Million in 2035. Read More

Which end user segment had the highest valuation in 2024?

In 2024, the Hospitals segment had the highest valuation at $8.0 Million. Read More

What is the projected valuation for the Ambulatory Surgical Centers segment by 2035?

The projected valuation for Ambulatory Surgical Centers is $10.0 Million by 2035. Read More

South Korea Structural Heart Devices Market

ID: MRFR/MED/55135-HCR

200 Pages

Satyendra Maurya

Last Updated: February 06, 2026

South Korea Structural Heart Devices Market Research Report: Size, Share, Trend Analysis By Types (Heart Valve Devices, Annuloplasty Rings, Occluders, Delivery Systems), By Indication (Valvular Heart Disease, Cardiomyopathy) andBy Procedure (Replacement Procedures, Repair Procedures)– Competitor Industry Analysis and Trends Forecast Till 2035

South Korea Structural Heart Devices Market Infographic

Summary Table of Contents Segmentation Download PDF

Certified Researchers

Customize Report

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Life Sciences, BY Type (USD Million)
  1. 4.1.1 Transcatheter Aortic Valve Replacement
  2. 4.1.2 Mitral Valve Repair Devices
  3. 4.1.3 Left Atrial Appendage Closure Devices
  4. 4.1.4 Transcatheter Pulmonary Valve
2. 4.2 Life Sciences, BY Procedure Type (USD Million)
  1. 4.2.1 Minimally Invasive
  2. 4.2.2 Surgical
  3. 4.2.3 Percutaneous
3. 4.3 Life Sciences, BY Indication (USD Million)
  1. 4.3.1 Aortic Stenosis
  2. 4.3.2 Mitral Regurgitation
  3. 4.3.3 Heart Failure
  4. 4.3.4 Pulmonary Valve Stenosis
4. 4.4 Life Sciences, BY End User (USD Million)
  1. 4.4.1 Hospitals
  2. 4.4.2 Ambulatory Surgical Centers
  3. 4.4.3 Cardiology Clinics
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Life Sciences
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Life Sciences
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Edwards Lifesciences (US)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Medtronic (US)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Abbott Laboratories (US)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Boston Scientific (US)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 LivaNova (GB)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Cardiac Dimensions (US)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 AtriCure (US)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Terumo Corporation (JP)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
  9. 5.2.9 JenaValve Technology (DE)
    1. 5.2.9.1 Financial Overview
    2. 5.2.9.2 Products Offered
    3. 5.2.9.3 Key Developments
    4. 5.2.9.4 SWOT Analysis
    5. 5.2.9.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 SOUTH KOREA MARKET ANALYSIS BY TYPE
3. 6.3 SOUTH KOREA MARKET ANALYSIS BY PROCEDURE TYPE
4. 6.4 SOUTH KOREA MARKET ANALYSIS BY INDICATION
5. 6.5 SOUTH KOREA MARKET ANALYSIS BY END USER
6. 6.6 KEY BUYING CRITERIA OF LIFE SCIENCES
7. 6.7 RESEARCH PROCESS OF MRFR
8. 6.8 DRO ANALYSIS OF LIFE SCIENCES
9. 6.9 DRIVERS IMPACT ANALYSIS: LIFE SCIENCES
10. 6.10 RESTRAINTS IMPACT ANALYSIS: LIFE SCIENCES
11. 6.11 SUPPLY / VALUE CHAIN: LIFE SCIENCES
12. 6.12 LIFE SCIENCES, BY TYPE, 2024 (% SHARE)
13. 6.13 LIFE SCIENCES, BY TYPE, 2024 TO 2035 (USD Million)
14. 6.14 LIFE SCIENCES, BY PROCEDURE TYPE, 2024 (% SHARE)
15. 6.15 LIFE SCIENCES, BY PROCEDURE TYPE, 2024 TO 2035 (USD Million)
16. 6.16 LIFE SCIENCES, BY INDICATION, 2024 (% SHARE)
17. 6.17 LIFE SCIENCES, BY INDICATION, 2024 TO 2035 (USD Million)
18. 6.18 LIFE SCIENCES, BY END USER, 2024 (% SHARE)
19. 6.19 LIFE SCIENCES, BY END USER, 2024 TO 2035 (USD Million)
20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 South Korea MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY TYPE, 2025-2035 (USD Million)
  2. 7.2.2 BY PROCEDURE TYPE, 2025-2035 (USD Million)
  3. 7.2.3 BY INDICATION, 2025-2035 (USD Million)
  4. 7.2.4 BY END USER, 2025-2035 (USD Million)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

South Korea Life Sciences Market Segmentation

Life Sciences By Type (USD Million, 2025-2035)

Transcatheter Aortic Valve Replacement
Mitral Valve Repair Devices
Left Atrial Appendage Closure Devices
Transcatheter Pulmonary Valve

Life Sciences By Procedure Type (USD Million, 2025-2035)

Minimally Invasive
Surgical
Percutaneous

Life Sciences By Indication (USD Million, 2025-2035)

Aortic Stenosis
Mitral Regurgitation
Heart Failure
Pulmonary Valve Stenosis

Life Sciences By End User (USD Million, 2025-2035)

Hospitals
Ambulatory Surgical Centers
Cardiology Clinics

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”